Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-11-01
|
Series: | Gynecologic Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578920301144 |
_version_ | 1818391632302571520 |
---|---|
author | Johnathan Oh Minal Barve Neil Senzer Phylicia Aaron Luisa Manning Gladice Wallraven Ernest Bognar Laura Stanbery Staci Horvath Meghan Manley John Nemunaitis Adam Walter Rodney P. Rocconi |
author_facet | Johnathan Oh Minal Barve Neil Senzer Phylicia Aaron Luisa Manning Gladice Wallraven Ernest Bognar Laura Stanbery Staci Horvath Meghan Manley John Nemunaitis Adam Walter Rodney P. Rocconi |
author_sort | Johnathan Oh |
collection | DOAJ |
first_indexed | 2024-12-14T05:16:36Z |
format | Article |
id | doaj.art-e43f4809d0e54d0cba6c51742a18b756 |
institution | Directory Open Access Journal |
issn | 2352-5789 |
language | English |
last_indexed | 2024-12-14T05:16:36Z |
publishDate | 2020-11-01 |
publisher | Elsevier |
record_format | Article |
series | Gynecologic Oncology Reports |
spelling | doaj.art-e43f4809d0e54d0cba6c51742a18b7562022-12-21T23:15:49ZengElsevierGynecologic Oncology Reports2352-57892020-11-0134100648Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenanceJohnathan Oh0Minal Barve1Neil Senzer2Phylicia Aaron3Luisa Manning4Gladice Wallraven5Ernest Bognar6Laura Stanbery7Staci Horvath8Meghan Manley9John Nemunaitis10Adam Walter11Rodney P. Rocconi12Texas Oncology, P.A., Dallas, TX, United StatesTexas Oncology, P.A., Dallas, TX, United States; Mary Crowley Cancer Research Centers, Dallas, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesGradalis, Inc., Carrolton, TX, United StatesCorresponding author at: 2545 Golden Bear Dr., Suite 110, Carrollton, TX 75006, United States.; Gradalis, Inc., Carrolton, TX, United StatesProMedica, Toledo, OH, United StatesUniversity of South Alabama - Mitchell Cancer Institute, Mobile, AL, United Stateshttp://www.sciencedirect.com/science/article/pii/S2352578920301144 |
spellingShingle | Johnathan Oh Minal Barve Neil Senzer Phylicia Aaron Luisa Manning Gladice Wallraven Ernest Bognar Laura Stanbery Staci Horvath Meghan Manley John Nemunaitis Adam Walter Rodney P. Rocconi Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance Gynecologic Oncology Reports |
title | Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance |
title_full | Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance |
title_fullStr | Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance |
title_full_unstemmed | Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance |
title_short | Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance |
title_sort | long term follow up of phase 2a trial results involving advanced ovarian cancer patients treated with vigil r in frontline maintenance |
url | http://www.sciencedirect.com/science/article/pii/S2352578920301144 |
work_keys_str_mv | AT johnathanoh longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT minalbarve longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT neilsenzer longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT phyliciaaaron longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT luisamanning longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT gladicewallraven longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT ernestbognar longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT laurastanbery longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT stacihorvath longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT meghanmanley longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT johnnemunaitis longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT adamwalter longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance AT rodneyprocconi longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance |